Author name: ipessentiacom

Sandostatin (Octreotide) LAR is used for treating acromegaly, carcinoid tumors, and neuroendocrine tumors, among other conditions. Novartis owned EP 2377519,

In a recent decision, the Swedish Patent and Market Court provided critical insights into the interpretation of Article 3(b) and

In the United Kingdom, multiple generic competitors initiated invalidity lawsuits seeking revocation of Bayer’s key dosing patent protecting Xarelto 10,

https://womenentrepreneurindia.com/digital-magazine/women-in-pharma-and-lifesciences-may-2022/#page=32     #womeninpharma #ipservices #patentservices

#honor #recognition #gratitude #ipessentia

Thanks, Garima & Sneha for discussing TICAGRELOR, DAPAGLIFLOZIN, CHLORANTRANILIPROLE and SAROGLITAZAR cases at length & sharing the shifting trend.  

Thanks, Bird & Bird, Life Sciences team…….. Mark Hilton & Jane Owen, for sharing the recent shift in Interim injunctions

Thanks, Dr. Roshan & Steve. For providing insights & practice tips based on the key Recent Cases and Trends in

https://www.siliconindia.com/digital-magazine/patent-and-trademark-law-services-july-2021/#page=23

Poonam Raghuvanshi Founder Analysing and strategizing Intellectual property has become relatively simpler today, with the help of Patent and Trademark